Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma.

11th Japan-Taiwan Conference on Otolaryngology – Head and Neck Surgery 2011

菊地正弘